Future studies would also be needed to validate whether the functional co‐operation of PTEN and PP2A extends to other cancers beyond PCa, and whether these findings would open novel therapeutic opportunities for simultaneously targeting both of these tumour suppressor phosphatases [53]. The gene discussed is PTEN; the disease is cancer.